India, June 4 -- Roche (RHHBY) has announced the rapid development of a Research Use Only (RUO) PCR test to detect the rare Ebola Bundibugyo virus, completing the assay within just six days of the genome sequence being published.
The test, created by Roche's subsidiary TIB MOLBIOL, is designed for use on LightCycler and cobas systems. It enables laboratories to quickly establish testing capabilities, supporting outbreak containment and providing critical surveillance to monitor further spread.
The World Health Organization (WHO) declared the outbreak in the Democratic Republic of Congo (DRC) and Uganda a Public Health Emergency of International Concern on 17 May 2026.
Roche highlighted that its "rapid response: library of 15,000 test pre...